Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Safety and practicability of using mid-upper arm circumference as a discharge criterion in community based management of severe acute malnutrition in children aged 6 to 59 months programmes.

Binns PJ, Dale NM, Banda T, Banda C, Shaba B, Myatt M.

Arch Public Health. 2016 Jun 15;74:24. doi: 10.1186/s13690-016-0136-x. eCollection 2016.

2.

Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.

Barth RF, Yang W, Nakkula RJ, Byun Y, Tjarks W, Wu LC, Binns PJ, Riley KJ.

Appl Radiat Isot. 2015 Dec;106:251-5. doi: 10.1016/j.apradiso.2015.06.031. Epub 2015 Jul 2.

3.

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

Barth RF, Vicente MG, Harling OK, Kiger WS 3rd, Riley KJ, Binns PJ, Wagner FM, Suzuki M, Aihara T, Kato I, Kawabata S.

Radiat Oncol. 2012 Aug 29;7:146. doi: 10.1186/1748-717X-7-146. Review.

4.

Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat glioma.

Barth RF, Yang W, Huo T, Riley KJ, Binns PJ, Grecula JC, Gupta N, Rousseau J, Elleaume H.

Appl Radiat Isot. 2011 Dec;69(12):1813-6. doi: 10.1016/j.apradiso.2011.03.019. Epub 2011 Mar 21.

PMID:
21493080
5.

A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy.

Kumar S, Freytag SO, Barton KN, Burmeister J, Joiner MC, Sedghi B, Movsas B, Binns PJ, Kim JH, Brown SL.

J Radiat Res. 2010;51(5):621-6.

6.

Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.

Kawabata S, Yang W, Barth RF, Wu G, Huo T, Binns PJ, Riley KJ, Ongayi O, Gottumukkala V, Vicente MG.

J Neurooncol. 2011 Jun;103(2):175-85. doi: 10.1007/s11060-010-0376-5. Epub 2010 Sep 17.

7.

Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.

Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ.

J Neurooncol. 2009 Dec;95(3):355-365. doi: 10.1007/s11060-009-9945-x. Epub 2009 Jul 9.

8.

An international dosimetry exchange for BNCT part II: computational dosimetry normalizations.

Riley KJ, Binns PJ, Harling OK, Albritton JR, Kiger WS 3rd, Rezaei A, Sköld K, Seppälä T, Savolainen S, Auterinen I, Marek M, Viererbl L, Nievaart VA, Moss RL.

Med Phys. 2008 Dec;35(12):5419-25.

PMID:
19175101
9.

Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.

Barth RF, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S, Tjarks W, Tordoff K, Moeschberger ML, Eriksson S, Binns PJ, Riley KJ.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17493-7. doi: 10.1073/pnas.0809569105. Epub 2008 Nov 3.

10.

Functional and histological changes in rat lung after boron neutron capture therapy.

Kiger JL, Kiger WS 3rd, Riley KJ, Binns PJ, Patel H, Hopewell JW, Harling OK, Busse PM, Coderre JA.

Radiat Res. 2008 Jul;170(1):60-9. doi: 10.1667/RR1266.1.

PMID:
18582158
11.

Unifying dose specification between clinical BNCT centers in the Americas.

Riley KJ, Binns PJ, Harling OK, Kiger WS 3rd, González SJ, Casal MR, Longhino J, Larrieu OA, Blaumann HR.

Med Phys. 2008 Apr;35(4):1295-8.

PMID:
18491523
12.

Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.

Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2008 Feb 1;14(3):883-91. doi: 10.1158/1078-0432.CCR-07-1968.

13.

Normalisation of prescribed dose in BNCT.

Binns PJ, Riley KJ, Harling OK, Albritton JR, Kiger WS 3rd.

Radiat Prot Dosimetry. 2007;126(1-4):610-4. Epub 2007 May 23.

PMID:
17522033
14.

No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome.

Schuller BW, Rogers AB, Cormier KS, Riley KJ, Binns PJ, Julius R, Hawthorne MF, Coderre JA.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):205-10.

PMID:
17448874
15.

Improved dose targeting for a clinical epithermal neutron capture beam using optional (6)Li filtration.

Binns PJ, Riley KJ, Ostrovsky Y, Gao W, Albritton JR, Kiger WS 3rd, Harling OK.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1484-91.

PMID:
17394946
16.

Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.

Wu G, Yang W, Barth RF, Kawabata S, Swindall M, Bandyopadhyaya AK, Tjarks W, Khorsandi B, Blue TE, Ferketich AK, Yang M, Christoforidis GA, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA.

Clin Cancer Res. 2007 Feb 15;13(4):1260-8.

17.

Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2006 Jun 15;12(12):3792-802.

18.

Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells.

Schuller BW, Binns PJ, Riley KJ, Ma L, Hawthorne MF, Coderre JA.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3787-92. Epub 2006 Feb 27.

19.

An international dosimetry exchange for boron neutron capture therapy. Part I: Absorbed dose measurements.

Binns PJ, Riley KJ, Harling OK, Kiger WS 3rd, Munck af Rosenschöld PM, Giusti V, Capala J, Sköld K, Auterinen I, Serén T, Kotiluoto P, Uusi-Simola J, Marek M, Viererbl L, Spurny F.

Med Phys. 2005 Dec;32(12):3729-36.

PMID:
16475772
20.

RBE of the MIT epithermal neutron beam for crypt cell regeneration in mice.

Gueulette J, Binns PJ, De Coster BM, Lu XQ, Roberts SA, Riley KJ.

Radiat Res. 2005 Dec;164(6):805-9.

PMID:
16296887
21.

The MIT user center for neutron capture therapy research.

Harling OK, Riley KJ, Binns PJ, Patel H, Coderre JA.

Radiat Res. 2005 Aug;164(2):221-9.

PMID:
16038593
22.
23.

A state-of-the-art epithermal neutron irradiation facility for neutron capture therapy.

Riley KJ, Binns PJ, Harling OK.

Phys Med Biol. 2004 Aug 21;49(16):3725-35.

PMID:
15446801
24.

Dosimetric measurements with a brain equivalent plastic walled ionization chamber in an epithermal neutron beam.

Binns PJ, Riley KJ, Harling OK.

Radiat Prot Dosimetry. 2004;110(1-4):687-92.

PMID:
15353731
25.

Tolerance of normal human brain to boron neutron capture therapy.

Coderre JA, Hopewell JW, Turcotte JC, Riley KJ, Binns PJ, Kiger WS 3rd, Harling OK.

Appl Radiat Isot. 2004 Nov;61(5):1083-7.

PMID:
15308196
26.

Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.

Kiger WS 3rd, Lu XQ, Harling OK, Riley KJ, Binns PJ, Kaplan J, Patel H, Zamenhof RG, Shibata Y, Kaplan ID, Busse PM, Palmer MR.

Appl Radiat Isot. 2004 Nov;61(5):1075-81.

PMID:
15308195
27.

Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.

Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):981-5.

PMID:
15308179
28.

Effects of boron neutron capture irradiation on the normal lung of rats.

Kiger JL, Kiger WS, Patel H, Binns PJ, Riley KJ, Hopewell JW, Harling OK, Coderre JA.

Appl Radiat Isot. 2004 Nov;61(5):969-73.

PMID:
15308177
29.

Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.

Barth RF, Wu G, Yang W, Binns PJ, Riley KJ, Patel H, Coderre JA, Tjarks W, Bandyopadhyaya AK, Thirumamagal BT, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):899-903.

PMID:
15308165
30.

Progress with the NCT international dosimetry exchange.

Binns PJ, Riley KJ, Harling OK, Auterinen I, Marek M, Kiger WS 3rd.

Appl Radiat Isot. 2004 Nov;61(5):865-8.

PMID:
15308159
31.

The design, construction and performance of a variable collimator for epithermal neutron capture therapy beams.

Riley KJ, Binns PJ, Ali SJ, Harling OK.

Phys Med Biol. 2004 May 21;49(10):2015-28.

PMID:
15214538
32.

Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.

Coderre JA, Turcotte JC, Riley KJ, Binns PJ, Harling OK, Kiger WS 3rd.

Technol Cancer Res Treat. 2003 Oct;2(5):355-75. Review.

PMID:
14529302
33.

Performance characteristics of the MIT fission converter based epithermal neutron beam.

Riley KJ, Binns PJ, Harling OK.

Phys Med Biol. 2003 Apr 7;48(7):943-58.

PMID:
12701897
34.

A physical dosimetry intercomparison for BNCT.

Riley KJ, Binns PJ, Greenberg DD, Harling OK.

Med Phys. 2002 May;29(5):898-904.

PMID:
12033586
35.

Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses.

Gueulette J, Bohm L, Slabbert JP, De Coster BM, Rutherfoord GS, Ruifrok A, Octave-Prignot M, Binns PJ, Schreuder AN, Symons JE, Scalliet P, Jones DT.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1051-8.

PMID:
10863078
36.

Direct determination of kerma for a d(48.5) + Be therapy beam.

Binns PJ, DeLuca PM Jr, Maughan RL, Kota C.

Phys Med Biol. 1998 Dec;43(12):3449-57.

PMID:
9869023
37.

The evaluation of nylon and polyethylene as build-up material in a neutron therapy beam.

Hough JH, Binns PJ.

Phys Med Biol. 1995 Jul;40(7):1289-92.

PMID:
7568383
38.

Consideration of radiation quality in treatment planning with p(66)/Be(40) neutrons.

Binns PJ, Hough JH.

Int J Radiat Oncol Biol Phys. 1992;24(5):975-81.

PMID:
1447039
39.

A quality assessment of the effects of a hydrogenous filter on a p(66)Be(40) neutron beam.

Slabbert JP, Binns PJ, Jones HL, Hough JH.

Br J Radiol. 1989 Nov;62(743):989-94.

PMID:
2819378
40.

A d(16) + Be fast neutron beam for therapy.

Hough JH, Binns PJ.

Radiother Oncol. 1987 Sep;10(1):71-5.

PMID:
3118420

Supplemental Content

Loading ...
Support Center